GE Ventures launches new digital medicine company

GE Ventures and Stanford Health Care (affiliated with Stanford University) just announced the launch of digital medicine company Evidation Health. "Our company has the core capabilities to make precision digital medicine a reality. We envision a digital health-enabled future where clinical interventions can be customized and concentrated in ways that maximize clinical and economic benefit for payers, providers and, most importantly, patients," said Evidation Health CEO Deborah Kilpatrick. The company completed a Series A financing in January led by GE Ventures, and also including Asset Management Ventures and Rock Health. The company boasts partnerships with Humana ($HUM), Biogen Idec ($BIIB), Sanofi ($SNY), Harvard Business School and Wharton business school. More

Suggested Articles

A decade-long study found that patients with early breast cancer may be spared radiation procedures that span the whole breast.

A cell therapy for Parkinson’s disease starts out simple, but quickly gets complicated with the potential for immune responses and cancer mutations.

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.